8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed May 6, 2026 · 1mo ago · Accession 0001171843-26-003052
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- 8-K
- Filing date
- May 6, 2026
- Report date
- May 6, 2026
- Document
- f8k_050626.htm
- Size
- 316 KB